Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 10 Dec 2025 18:15 CET |
ONCOINVENT ASA | Oncoinvent ASA: New share capital registered | 20103010 Biotechnology | Total number of voting rights and capital |
| 08 Dec 2025 10:49 CET |
ONCOINVENT ASA | Flaggemelding – Hadean Ventures AS / HVentures AB / Hadean Growth Fund I AS1 – Oncoinvent AS (ONCIN) | 20103010 Biotechnology | Flagging |
| 08 Dec 2025 07:00 CET |
ONCOINVENT ASA | Oncoinvent Announces Publication of Phase 1 Study Results for Radspherin® in Ovarian Cancer in Gynecologic Oncology | 20103010 Biotechnology | Non-regulatory press releases |
| 08 Dec 2025 06:55 CET |
ONCOINVENT ASA | Oncoinvent ASA: Notification of trade - primary insider/close associate | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 05 Dec 2025 14:01 CET |
ONCOINVENT ASA | NOTIFICATION OF MAJOR HOLDINGS | 20103010 Biotechnology | Major shareholding notifications |
| 05 Dec 2025 13:13 CET |
ONCOINVENT ASA | Oncoinvent ASA: Resolution to increase the share capital in connection with settlement of underwriting fee | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 05 Dec 2025 13:05 CET |
ONCOINVENT ASA | Oncoinvent ASA: Minutes from Extraordinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Dec 2025 08:02 CET |
ONCOINVENT ASA | Flaggemelding - MP Pensjon PK | 20103010 Biotechnology | Flagging |
| 02 Dec 2025 15:17 CET |
ONCOINVENT ASA | Oncoinvent ASA: Notification of trade - primary insider/close associate | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 02 Dec 2025 12:21 CET |
ONCOINVENT ASA | Oncoinvent ASA: Final results of the rights issue | 20103010 Biotechnology | Inside information |
| 01 Dec 2025 18:45 CET |
ONCOINVENT ASA | Oncoinvent ASA: Preliminary results of the rights issue | 20103010 Biotechnology | Inside information |
| 01 Dec 2025 07:00 CET |
ONCOINVENT ASA | Oncoinvent ASA: Last day of the subscription period in the rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Nov 2025 12:59 CET |
ONCOINVENT ASA | Oncoinvent ASA: Notification of trade - primary insider/close associate | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 25 Nov 2025 06:37 CET |
Oncoinvent ASA | Oncoinvent ASA: Last day of trading in subscription rights | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Nov 2025 06:30 CET |
Oncoinvent ASA | Oncoinvent ASA: Commencement of the subscription period for the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 14 Nov 2025 15:45 CET |
ONCOINVENT ASA | Oncoinvent ASA: Notice of Extraordinary General Meeting in connection with the Rights Issue | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 14 Nov 2025 14:51 CET |
ONCOINVENT ASA | Oncoinvent ASA - Receipt of subscription rights in the rights issue by primary insiders and their close associates | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 14 Nov 2025 10:56 CET |
ONCOINVENT ASA | Oncoinvent ASA - Receipt of subscription rights in the rights issue by primary insiders and their close associates | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 12 Nov 2025 07:00 CET |
ONCOINVENT ASA | Oncoinvent ASA: EX. SUBSCRIPTION RIGHTS IN RIGHTS ISSUE TODAY | 20103010 Biotechnology | Ex Date |
| 11 Nov 2025 18:16 CET |
ONCOINVENT ASA | Oncoinvent ASA: Terms of the underwritten Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Nov 2025 17:32 CET |
ONCOINVENT ASA | Oncoinvent ASA: Updated Key Information related to the contemplated Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Nov 2025 12:55 CET |
ONCOINVENT ASA | Reminder: Invitation to presentation of Q3 2025 company update on November 4[th], 2025 | 20103010 Biotechnology | Non-regulatory press releases |
| 03 Nov 2025 12:15 CET |
ONCOINVENT ASA | NOTIFICATION OF MAJOR HOLDINGS | 20103010 Biotechnology | Major shareholding notifications |
| 03 Nov 2025 11:49 CET |
ONCOINVENT ASA | Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 03 Nov 2025 10:09 CET |
ONCOINVENT ASA | Flaggemelding | 20103010 Biotechnology | Flagging |
| 03 Nov 2025 09:39 CET |
ONCOINVENT ASA | Flaggemelding – Hadean Ventures AS / HVentures AB – Oncoinvent AS (ONCIN) | 20103010 Biotechnology | Flagging |
| 03 Nov 2025 08:55 CET |
ONCOINVENT ASA | Mandatory notification of trade | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 31 Oct 2025 08:30 CET |
ONCOINVENT ASA | Oncoinvent appoints Dr. Ramzi Amri as new CFO | 20103010 Biotechnology | Non-regulatory press releases |
| 29 Oct 2025 22:17 CET |
BERGENBIO | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Oct 2025 17:35 CET |
BERGENBIO | Merger of BerGenBio and Oncoinvent completed | 20103010 Biotechnology | Total number of voting rights and capital |
| 29 Oct 2025 07:00 CET |
BERGENBIO | BerGenBio and Oncoinvent - Last day of trading in the shares of Oncoinvent | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Oct 2025 10:42 CET |
BERGENBIO | BerGenBio ASA: Approval and publication of prospectus | 20103010 Biotechnology | Prospectus / admission document |
| 24 Oct 2025 08:00 CEST |
BERGENBIO | BerGenBio and Oncoinvent - Key Dates for Completion of Merger | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Sep 2025 08:56 CEST |
BERGENBIO | BerGenBio ASA: Updated Key Information related to the contemplated Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Sep 2025 08:55 CEST |
BERGENBIO | BerGenBio ASA: Updated information regarding the contemplated Rights Issue and Merger | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 Aug 2025 07:00 CEST |
BERGENBIO | BerGenBio First half results 2025 | 20103010 Biotechnology | Half yearly financial reports and audit reports/limited reviews |
| 05 Aug 2025 16:49 CEST |
BERGENBIO | BerGenBio ASA - Updated key information related to the rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Aug 2025 13:40 CEST |
BERGENBIO | BerGenBio ASA: Approval of the merger plan and the fully underwritten rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Jul 2025 14:53 CEST |
BERGENBIO | BerGenBio ASA: Notice of Extraordinary General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Jun 2025 22:30 CEST |
BERGENBIO | BerGenBio ASA - Key information related to the rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Jun 2025 22:05 CEST |
BERGENBIO | Announcement of fully underwritten rights issue | 20103010 Biotechnology | Inside information |
| 30 Jun 2025 22:00 CEST |
BERGENBIO | BerGenBio and Oncoinvent, a rising innovator in radiopharmaceutical cancer therapies, announce proposed merger and a fully underwritten rights issue | 20103010 Biotechnology | Inside information |
| 26 Jun 2025 11:29 CEST |
BERGENBIO | BerGenBio ASA - Minutes from the annual general meeting 2025 | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Jun 2025 19:22 CEST |
BERGENBIO | BerGenBio ASA: Update on Strategic Review Process and Status of Activities | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 Jun 2025 15:55 CEST |
BERGENBIO | BerGenBio ASA: Notice of Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Apr 2025 09:51 CEST |
BERGENBIO | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Apr 2025 22:03 CEST |
BERGENBIO | BerGenBio ASA: Board approval of 2024 Annual financial statement and Annual Report 2024 and update on financial calendar | 20103010 Biotechnology | Annual financial and audit Reports |
| 26 Mar 2025 07:00 CET |
BERGENBIO | BerGenBio announces Nature Communications Publication of BGBC003 Ph2 data in relapsed/refractory Acute Myeloid Leukemia patients | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Mar 2025 07:00 CET |
BERGENBIO | BerGenBio announces advancement of its strategic review | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 26 Feb 2025 07:00 CET |
BERGENBIO | BerGenBio Fourth Quarter Results 2024 | 20103010 Biotechnology | Inside information |